Top 10 DNA Data Storage Companies

The DNA Data storage market is projected to grow from USD 76 million in 2024 and is expected to reach USD 3,348 million by 2030, growing at a CAGR of 87.7% from 2024 to 2030. The demand for data storage is growing exponentially, driven by the increasing digitization of businesses and societies. For instance, Cloud computing providers need to store large amounts of data for their customers, so the growth of cloud computing is leading to the need for increased data storage capacity. DNA data storage has the potential to meet this demand by offering a high-density, durable, and secure way to store data. DNA is incredibly dense, meaning that it can store large amounts of data in a small space. Additionally, DNA is very durable and can last for thousands of years. This makes DNA ideal for long-term archival storage of critical data.

Major players in the DNA Data storage market include

• Illumina, Inc. (US),
• Microsoft (US),
• Iridia, Inc. (US),
• Twist Bioscience (US),
• Catalog (US),
• Thermo Fisher Scientific Inc.  (US),
• Micron Technology, Inc. (US)
• Helixworks Technologies Ltd (Ireland),
• Agilent Technologies, Inc. (US),
• Beckman Coulter (US), Eurofins Scientific (Luxembourg) Siemens (Germany). Collaborations and acquisitions were the key strategies adopted by the players in the DNA Data storage market ecosystem to enhance their product portfolios and expand their presence in the DNA Data storage market.

To know about the assumptions considered for the study download the pdf brochure

For instance, in September 2022, Catalog (US) announced a collaboration with Seagate Technology LLC (Ireland). The collaboration of Catalog and Seagate Technology LLC focused on developing several initiatives to advance scalable and automated DNA-based storage and computation platforms, including making DNA-based platforms up to 1000 times smaller. The collaboration will center on using Seagate's “lab on a chip” technology to reduce the volume of chemistry required for DNA-based storage and computation. This research will provide valuable insights into possibilities for the next generation of DNA-based storage and computation platforms in various form factors, including desktop and IoT-sized versions.

In November 2022, Illumina, Inc. (US) announced a collaboration with AstraZeneca (UK). The collaboration leverages Illumina's next generation of AI-based interpretation tools. PrimateAI and SpliceAI, in combination with AstraZeneca's analysis framework are working towards rare variant genomic discoveries—alongside the latter's own AI tools, including JARVIS and in silico predictors like missense tolerance ratio. As part of the research collaboration a framework combining the two companies' AI-based tools will be adopted by AstraZeneca's Centre for Genomics Research to analyze large-scale multi-omics data sets in its digital biobank.

Illumina, Inc. (US) is one of the leading biotechnology company known for its contributions to genomics and DNA sequencing technologies. Illumina has played a pivotal role in advancing genomic research and precision medicine. The company's mission is to improve human health by unlocking the power of the genome. The company is majorly operating in two business segments i.e., Core illumina and Grail under which core illumine includes the company’s next-generation sequencing (NGS) systems and consumables, such as flow cells, reagents, and kits and grail being a newly created segment includes the company's early detection cancer screening technology. Moreover, the company is known for its DNA sequencing platforms, which have revolutionized genomics research.

Iridia, Inc. (US) is a nanotechnology company that specializes in biochemistry, molecular biology, and DNA. It develops the world’s first commercially attractive, DNA-based data storage solution that combines DNA polymer synthesis technology, electronic nano-switches, and semiconductor fabrication technologies. Iridia developed a highly parallel format toenable an array of nanomodules with the potential to store data at exceptionally high density. By combining unique and proprietary DNA synthesis chemistry, unique hardware architecture and semiconductor fabrication technologies, Iridia develops a first in class solutions to seamlessly write, store, and read data at exceptionally high density. The focus is for decentralized, affordable DNA data storage that enables communities, companies or even families the ability to store and manage their data

Related Reports:

DNA Data Storage Market by Type (Cloud, On-Premises), Technology (Sequence-based DNA Data Storage, Structure-based DNA Data Storage), End Users (Government, Healthcare & Biotechnology, Media & Telecommunication) and Geography - Global Forecast to 2030

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]